Myasthenia gravis
69 results
1 - 69
Myasthenia gravis 
Corticosteroids for myasthenia gravis- Plasma exchange for generalised myasthenia gravis
- Acetylcholinesterase inhibitor treatment for myasthenia gravis
- Corticosteroids for myasthenia gravis
- Plasma exchange for myasthenia gravis
- Intravenous immunoglobulin for myasthenia gravis: Cochrane systematic review
- Acetylcholinesterase inhibitor treatment for myasthenia gravis
- Immunosuppressive agents for myasthenia gravis
- Immunosuppressive agents for myasthenia gravis
- Thymectomy for non‐thymomatous myasthenia gravis
- Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes: Cochrane systematic review
- Rituximab for myasthenia gravis
- Intravenous immunoglobulin for exacerbations of myasthenia gravis
Inebilizumab modestly improves symptoms of myasthenia gravis but only when placebo group has treatment (steroids) withdrawn- Signs, symptoms, and simple tests in the diagnosis of myasthenia gravis
- Medical and surgical treatment for ocular myasthenia
- Muscle weakness and paralysis symptom
- Eye symptoms and signs of systemic diseases
- Hereditary myopathies
- Guillain-Barré syndrome (polyradiculitis)
- Myositis
- Neurological eye symptoms
- Ptosis
- Oral lichen planus
- Food poisoning
- Dysphagia
- Respiratory failure
- Respiratory muscle training in children and adults with neuromuscular disease
- Treatment for Lambert-Eaton myasthenic syndrome
- Treatment for Lambert‐Eaton myasthenic syndrome
- Urinary incontinence in women